Australia cracks down on unproven stem cell therapies
As in the US, unproven stem cell therapies have been marketed in Australia.Therapeutic Goods Administration (TGA, similar to US FDA) of the Australian Government tightened regulations around advertising autologous (self) human cell and tissue products.
As of July 1, 2018, these products cannot be marketed to consumers, and adverse events must be reported to the TGA.
Interested in learning whether current clinical programs, research developments, or emerging therapeutic approaches may be relevant to your situation?
Educational and research information only. Individual medical decisions should be made in consultation with qualified healthcare professionals.
